This disclosure relates generally to the field of medical devices, systems and methods for use in surgical procedures. More specifically, this disclosure relates to electrosurgical devices, systems and methods that provide for cutting, coagulation, hemostasis, or sealing of bodily tissues including bone with an electrosurgical device.
Electrosurgery includes such techniques as cutting, coagulation, hemostasis, and/or sealing of tissues with the aid of electrodes energized with a suitable power source. Typical electrosurgical devices apply an electrical potential difference or signal between an active electrode and a return electrode on a patient's grounded body in a monopolar arrangement or between an active electrode and a return electrode on the device in bipolar arrangement to deliver electrical energy to the area where tissue is to be affected. The electrosurgical devices are typically held by the surgeon and connected to the power source, such as an electrosurgical unit having a power generator, via cabling.
Electrosurgical devices pass electrical energy through tissue between the electrodes to provide coagulation to control bleeding and hemostasis to seal tissue. Electrosurgical devices can also cut tissue through the use of plasma formed on the electrode. Tissue that contacts the plasma experiences a rapid vaporization of cellular fluid to produce a cutting effect. Typically, cutting and coagulation are often performed with electrodes in the monopolar arrangement while hemostasis is performed with electrodes in the bipolar arrangement.
Electrical signals can be applied to the electrodes either as a train of high frequency pulses or as a continuous signal typically in the radiofrequency (RF) range to perform the different techniques. The signals can include a variable set of parameters, such as power or voltage level, waveform parameters such as frequency, pulse duration, duty cycle, and other signal parameters that may be particularly apt or preferred for a given technique. For example, a surgeon could cut tissue using a first RF signal having a set of parameters to form plasma and control bleeding using a second RF signal having another set of parameters more preferred for coagulation. The surgeon could also use electrodes in a bipolar arrangement or a bipolar electrosurgical device for hemostatic sealing of the tissue that would employ additional RF signals having another set of parameters.
Historically, two distinct electrosurgical devices, one monopolar and the other bipolar, were used to perform different functions in surgery, such as tissue cutting and coagulating and tissue sealing. For example a surgeon would use a monopolar electrosurgical device to cut and coagulate tissue and use a bipolar electrosurgical device to seal the tissue. When different techniques or functions were performed during a surgical procedure, surgeons would switch between different devices. Switching between devices can lead to undesirable effects such as longer procedure times, longer response times to issues that unexpectedly develop during surgery, higher costs, and an increased likelihood of inaccuracy or imprecision.
To address these issues, some electrosurgical devices capable of performing multiple techniques such as cutting and coagulating tissue or cutting, coagulating, and sealing tissue, including fluid-assisted sealing of tissue, have been developed. Several such electrosurgical device are described, for example, in U.S. Pat. No. 8,632,533 to Greeley, et al., U.S. Patent Application Publication No. 2012/000465 to Conley, et al., U.S. Patent Application Publication No. 2011/0178515 to Bloom et al., each assigned to the assignee of the present disclosure and incorporated by reference herein in their entireties to the extent they are not inconsistent with the present disclosure.
Several devices that have been developed include a hand piece having two electrodes. These devices can be configured as bipolar electrodes connected to a source of bipolar power to operate in a bipolar mode, for example to seal tissue. To operate the same two-electrode device in a monopolar mode, for example to cut tissue, one of the two electrodes may be selectively deactivated and the other of the two electrodes coupled to a source of monopolar power. In this manner, the multiple function device may provide treatment to tissue utilizing one or both electrodes depending upon the desired tissue treatment.
Despite having the ability to perform different functions with a single device, when monopolar function is desired only one of the two electrodes of the device are utilized and the deactivated second electrode may obstruct the view of the surgeon during the monopolar operation. Furthermore, the deactivated electrode may unnecessarily prevent the monopolar electrode from entering smaller spaces or tissue areas that could otherwise be accessed if the unused electrode was not exposed. Further still, devices may not perform similarly to independent bipolar and monopolar devices.
This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description.
In one aspect, the disclosure relates to an electrosurgical device having a handpiece including a controller and an electrode assembly extending from the handpiece. The electrode assembly includes a monopolar blade and a monopolar electrode. The monopolar blade includes a conductive element partially coated with an insulator and electrically coupled to the controller to selectively deliver a monopolar radiofrequency (RF) cutting signal. The monopolar electrode is spaced apart and electrically isolated from the monopolar blade. The monopolar electrode includes an exposed major conductive surface electrically coupled to the controller to selectively deliver a monopolar RF hemostatic sealing signal with a dispersed fluid. In one example, the controller includes a pushbutton to electrically couple the monopolar blade to the monopolar electrode before electrically coupling the monopolar RF hemostatic sealing signal to the monopolar electrode.
In one aspect, the disclosure relates to an electrosurgical device having a handpiece and an electrode assembly extending from the handpiece. The electrosurgical device is configured to be used with an electrosurgical generator unit and a return electrode. The electrode assembly includes an electrically insulative intermediate component coupled to, and electrically isolating, a monopolar blade and a monopolar electrode. The monopolar blade and monopolar electrode can be configured as active electrodes in a monopolar arrangement. The electrosurgical device is configured to deliver a monopolar RF signal for cutting and a monopolar RF signal for coagulating to the monopolar blade. The electrode assembly is also configured to disperse a fluid, such as saline, and deliver a monopolar RF signal for hemostatic sealing with the monopolar electrode.
In one aspect, the disclosure relates to an electrosurgical device having a handpiece including a controller. A shaft extends from the handpiece. The shaft includes a hypotube configured to deliver a fluid and includes a conductive element. An electrode assembly extends from the shaft. The electrode assembly includes a monopolar blade and a monopolar electrode. The monopolar blade includes a conductive element partially coated with an insulator and electrically coupled to the controller to selectively deliver a monopolar radiofrequency (RF) cutting signal. The monopolar electrode is spaced apart and electrically isolated from the monopolar blade. The monopolar electrode includes an exposed major conductive surface electrically coupled to the controller via the conductive element to selectively deliver a monopolar RF hemostatic sealing signal with a dispersed fluid via the hypotube. In one example, the shaft has a variable length, and the hypotube includes an extendable and yieldably collapsible coil segment.
The monopolar blade in one example desiccates tissue with the monopolar RF signal for cutting via plasma. The creation of plasma to cut tissue includes producing a very high current density in the monopolar blade. In the monopolar arrangement, the active electrode is generally much smaller than the return electrode to allow the plasma to form at the active electrode and not at the return electrode. In order to further increase the current density, reduce the power used to cut tissue in the monopolar arrangement, or a combination of both, the monopolar blade may include a conductive element such as stainless steel partially coated with an electrically insulative material such as glass or ceramic to leave a small exposed area of the conductive element to create the plasma on the monopolar blade. The glass or ceramic insulator also serves as a thermal shield, which reduces the heat on the outer surface of the monopolar blade in the locations of conductive element covered with the insulator, to protect areas of tissue from thermal damage.
The conductive element and insulative coating cooperate to form a sturdy, substantially sized cutting blade having only a fraction of the conductive surface area of a similarly sized metal blade to increase the current density and reduce the size of a thermal damage zone. Thus, the monopolar conductive element serves to harness and focus the monopolar energy allowing it to create plasma for precise dissection and coagulation with reduced power, a higher current density at the conductive element, or a combination of reduced power and higher current density than available in a similarly sized metal blade.
The monopolar electrode is configured from an uncoated metal to be substantially larger in conductive surface area than the monopolar blade. The monopolar electrode is configured to avoid creating plasma, and to produce a relatively low current density, with the monopolar RF signal for hemostatic sealing. Furthermore, the monopolar electrode of the examples is configured with a fluid port to disperse a fluid for hemostatic sealing. In one example, an electrically conductive hypotube is electrically coupled to the monopolar electrode and fluidly coupled to the fluid port to deliver the monopolar RF signal for hemostatic sealing to the monopolar electrode and to disperse an energized conductive fluid. The intermediate component electrically insulates the monopolar electrode and hypotube from the monopolar blade.
The electrode assembly can be readily fabricated on a large scale. In one example, the hypotube is welded to the monopolar electrode, which are overmolded with an electrically insulative plastic, such as polytetraflouroethylene (PTFE) based material or others, to form the intermediate component. The monopolar blade is attached to the intermediate component. The electrode assembly can be electrically coupled to a controller, fluidly coupled to tubing, and welded to a shaft of a handpiece to form the electrosurgical device.
The monopolar blade can be specifically configured for cutting or desiccating tissue and operated with cutting and coagulating RF energy, which is performed with a relatively high impedance electrode and a high current density to form plasma. The monopolar electrode can be specifically configured to perform the techniques of hemostatic tissue sealing, which is performed with a relatively lower impedance electrode and a lower current density and a dispersed fluid. Thus, a clinician can perform multiple electrosurgical functions without having to change devices, or from monopolar to bipolar mode or vice versa.
Throughout the description, like reference numerals and letters indicate corresponding structure throughout the several views. Also, any particular features(s) of a particular exemplary embodiment may be equally applied to any other exemplary embodiment(s) of this specification as suitable. That is, features between the various exemplary embodiments described herein are interchangeable as suitable and may not be exclusive. From the specification, it should be clear that the terms “distal” and “proximal” are made in reference to a user of the device.
The system 60 can be carried on a movable cart 2 having a support member 4 comprising a hollow cylindrical post which includes a platform 6 comprising a pedestal table to provide a flat, stable surface for location of the electrosurgical unit 10. Cart 2 can include a pole 8 having a height that can be adjusted by sliding the pole 8 up and down. Fluid source 20 can be supported at the top of pole 8.
Fluid source 20 may comprise a bag of fluid from which fluid 12 may flow through a drip chamber 14, to delivery tubing 16 and to handheld electrosurgical device 30. In one example, the fluid 12 includes saline and can include physiologic saline such as sodium chloride (NaCl) 0.9% weight/volume solution. Saline is an electrically conductive fluid, and other suitable electrically conductive fluids can be used. In other examples, the fluid may include a nonconductive fluid, such as deionized water, which may still provide advantages over using no fluid and may support cooling of portions of electrosurgical device 30 and tissue or reducing the occurrence of tissue sticking to the electrosurgical device 30.
The fluid delivery tubing 16 in the example passes through pump 22 to convey fluid to the electrosurgical device 30 and control fluid flow. Pump 22 in one example is a peristaltic pump such as a rotary peristaltic pump or a linear peristaltic pump. A peristaltic pump can convey the fluid through the delivery tubing 16 by way of intermittent forces placed on the external surface of the delivery tubing. Peristaltic pumps are often applied during use of the electrosurgical device 30 because the mechanical elements of the pump places forces on the external surface of the delivery tubing and do not come into direct contact with the fluid, which can reduce the likelihood of fluid contamination. Other examples of system 60 might not include a pump, and fluid can be is provided to the electrosurgical device 30 via gravity.
The example electrosurgical unit 10 can provide at least one or more monopolar RF power outputs to a specified electrosurgical instrument such as electrosurgical device 30. In one example, the electrosurgical unit 10 can be used for delivery of RF energy to instruments indicated for cutting and coagulation of soft tissue and for delivery of RF energy concurrent with fluid to instruments indicated for hemostatic sealing and coagulation of soft tissue and bone. In one example, the electrosurgical unit 10 can be capable of simultaneously or separately powering specified monopolar electrodes.
During monopolar operation of electrosurgical device 30, an active electrode is provided with electrosurgical device 30 while an indifferent, or neutral, electrode is provided in the form of a ground pad dispersive electrode located on a patient. For example, the ground pad dispersive electrode is typically on the back, buttocks, upper leg, or other suitable anatomical location during surgery. In such a configuration, the ground pad dispersive electrode is often referred to as a patient return electrode. An electrical circuit of RF energy is formed between the active electrode and the ground pad dispersive electrode through the patient. (In comparison, bipolar electrosurgical devices include a second electrode, often referred to as the return electrode providing a second electrical pole. The ground pad dispersive electrode is not used. An electrical circuit of RF energy is created between the first and second poles of a bipolar device. The current no longer flows through the patient's body to the ground pad dispersive electrode, but rather through a localized portion of tissue between the poles of the bipolar device.)
The electrosurgical device 30 in the example is connected to electrosurgical unit 10 via cable 24. Cable 24 includes plugs 34 that connect with receptacles 36 on the electrosurgical unit 10. In one example, a receptacle can correspond with an active electrode receptacle and one or more receptacles can correspond with controls on the electrosurgical device 30. Still further, a receptacle can correspond with a second active electrode receptacle. An additional cable may connect a ground pad electrode to a ground pad receptacle of the electrosurgical unit 10. In some examples, delivery tubing 16 and cable 24 are combined to form a single cable 26.
The features of electrosurgical unit 10 described are for illustration, and the electrosurgical units suitable for use with device 30 may include some, all, or other features than those described below. In one example, the electrosurgical unit 10 is capable of operating in at least monopolar mode as well as multiple functions within the monopolar mode such as a monopolar cutting function, a monopolar coagulation function, and monopolar hemostasis or tissue sealing function. In the monopolar cutting function, monopolar RF energy is provided to the device 30 at a first power level and/or a first waveform (collectively first, or cutting RF energy setting). For example, cutting RF energy for a cut function may be provided at a relatively low voltage and a continuous current (100% on, or 100% duty cycle). Nominal impedance can range between 300 to 1000 ohms for the cutting function. At a power setting of 90 Watts for cutting, voltage can range from approximately 164 to 300 volts root mean square (RMS). In the monopolar coagulation function, monopolar RF is energy is provided to the electrode at a second power level and/or second waveform (collectively second, or coagulating RF energy setting) that is different than at least one of the first power level or the first waveform. For example, coagulating RF energy for a coagulation function may be provided at a relatively higher voltage than the cut voltage and with a pulsed current, such as 1% to 6% on and 99% to 94% off, respectively (or 1% to 6% duty cycle). Other duty cycles are contemplated. The electrosurgical unit 10 may provide monopolar RF energy at a third power level and/or third waveform (collectively third, or hemostatic sealing RF energy setting) along with fluid for a (generally low voltage) hemostasis or tissue sealing function that may be the same as or different than the cutting and coagulating RF settings provided to the device 30 for the cut function or the coagulation function. In one example, hemostatic sealing energy can be provided with a continuous current (100% duty cycle). Nominal impedance can range between 100 to 400 ohms for the hemostatic sealing function. At a power setting of 90 Watts for hemostatic sealing, voltage can range from approximately 95 to 200 volts RMS.
In one example, the electrosurgical unit 10 provides RF energy to the active electrode as a signal having a frequency in the range of 100 KHz to 10 MHz. Typically this energy is applied in the form of bursts of pulses. Each burst typically has a duration in the range of 10 microseconds to 1 millisecond. The individual pulses in each burst typically each have a duration of 0.1 to 10 microseconds with an interval between pulses of 0.1 to 10 microseconds. The actual pulses are often sinusoidal or square waves and bi-phasic, that is alternating positive and negative amplitudes. Several other features are described in U.S. Pat. No. 8,323,276, to Palanker et al., and incorporated by reference herein in its entirety to the extent it is not inconsistent with the present disclosure.
The electrical surgical unit 10 includes a power switch to turn the unit on and off and an RF power setting display to display the RF power supplied to the electrosurgical device 30. The power setting display can display the RF power setting numerically in a selected unit such as watts.
The example electrosurgical unit 10 includes an RF power selector comprising RF power setting switches that are used to select or adjust the RF power setting. A user can push one power setting switch to increase the RF power setting and push the other power setting switch to decrease the RF power setting. In one example, power setting switches are membrane switches, soft keys, or as part of a touchscreen. In another example, the electrosurgical unit may include more than one power selectors such as a power selector corresponding with each of the different monopolar settings used in the different functions.
The example electrosurgical unit 10 can also include fluid flow rate setting display and flow rate setting selector. The display can include indicator lights, and the flow rate selector can include switches. Pushing one of the flow rate switches selects a fluid flow rate, which is than indicated in display.
While not being bound to a particular theory, the relationship between the variables of fluid flow rate Q (such as in units of cubic centimeters per minute (cc/min)) and RF power setting Ps (such as in units of watts) can be configured to inhibit undesired effects such as tissue desiccation, electrode sticking, smoke production, char formation, and other effects while not providing a fluid flow rate Q at a corresponding RF power setting Ps not so great as to disperse too much electricity and or overly cool the tissue at the electrode/tissue interface. Electrosurgical unit 10 is configured to increase the fluid flow rate Q generally linearly with an increasing RF power setting Ps for each of the three fluid flow rate settings of low, medium, and high.
Electrosurgical unit 10 can be configured to include control of the pump 22. In this example, the speed of the pump 22, and the fluid throughput, can be predetermined based on input variables such as the RF power setting and the fluid flow rate setting. In one example, the pump 22 can be integrated with the electrosurgical unit 10.
Several electrosurgical units, or generators, are described, for example, in U.S. patent application Ser. No. 14/927,999 to Smith, et al., titled RF Output Stage Switching Mechanism, filed Oct. 30, 2015; U.S. patent application Ser. No. 14/928,020 to Hubelbank, et al., titled Finger Switch Circuitry to Reduce Leakage Current, filed Oct. 30, 2015; U.S. patent application Ser. No. 14/927,969 to Smith, et al., titled Power Monitoring Circuitry and Method for Reducing Leakage Current in RF Generators, filed Oct. 30, 2015; and U.S. Patent Application Publication No. 2006/0149225 to McClurken, each assigned to the assignee of the present disclosure and incorporated by reference herein in their entireties to the extent they are not inconsistent with the present disclosure.
While electrosurgical device 30 is described with reference to electrosurgical unit 10 and other elements of system 60, it should understood the description of the combination is for the purposes of illustrating system 60. It may be possible to use the electrosurgical device 30 in other systems or the electrosurgical unit 10 may be used with other electrosurgical devices.
Electrosurgical device 70 extending along longitudinal axis A includes a handpiece 80. Handpiece 80 includes a handle 82 having a finger grip portion 84 with ridges shown on the lower surface or bottom B of the device 70 and intended to be held in the surgeon's hand. The handpiece 80 includes a proximal end 86 for balance and, in the example, includes an electrical connector for electrically coupling cable 24 to the device 70.
Handpiece 80 may be configured to enable a user of electrosurgical device 70 to hold and manipulate device 70 between the thumb and index finger like a writing instrument or an electrosurgical pen. Handpiece 80 may comprise a sterilizable, rigid, electrically insulative material, such as a synthetic polymer (e.g., polycarbonate, acrylonitrile-butadiene-styrene). The handle 82 can include an upper surface, or top T, opposite bottom B. A controller 88, such as a set of one or more switches coupled to circuitry such as on a printed circuit board, in the example is disposed on top T and configured to be operated by the user's thumb or index finger to activate the electrode assembly 100.
The electrosurgical device 70 can include a probe assembly 90 extending distally from the handpiece 80. The probe assembly 90 in the example includes a body portion 92 attached to a shaft 94. The shaft 94, or other portions of electrosurgical device 70 may include one or more elements forming a subassembly to be generally one or more of rigid, bendable, fixed-length, variable-length (including telescoping or having an axially-extendable or axially-retractable length) or other configuration. An example of an electrosurgical device having a telescoping shaft is described in U.S. Patent Application Publication No. 2016/0120592 to Sylvester, et al. assigned to the assignee of the present disclosure and incorporated by reference herein in its entirety to the extent it is not inconsistent with the present disclosure. The shaft 94 carries one or more electrical conductors to a distal end 96 including the electrode assembly 100. The electrode assembly 100 includes a distal tip 98. Electrical pathways within the handpiece 80 and probe assembly 90 can be formed as conductive arms, wires, traces, other conductive elements, and other electrical pathways formed from electrically conductive material such as metal and may comprise stainless steel, titanium, gold, silver, platinum or any other suitable material. In the example, the shaft 94 includes a fluid lumen extending into the handpiece 80 for fluidly coupling to delivery tubing 16 in cable 26. The fluid lumen includes an outlet port 106 disposed on the electrode assembly 100 for selectively dispersing fluid 12.
In one example, the controller 88 includes one or more pushbuttons on the handle 82 in combination with circuitry such as a PCB within the electrosurgical device 70 to provide binary activation (on/off) control for each function. For example, one button 88a may be pressed to activate the monopolar blade 102 in a cut function, another button 88b may be pressed to activate the monopolar blade 102 in a coagulation function, and still another button 88c may be pressed to activate the monopolar electrode 104 and disperse fluid from port 106 in a sealing function and disperse fluid 12. Alternate configurations of the controller 88 and its activation are contemplated. In one example, the monopolar electrode 104 is not active (and fluid is not dispersed from fluid port 106) when cutting and coagulating RF energy is provided to the monopolar blade 102, but the monopolar blade 102 is active when hemostatic sealing RF energy is provided to the monopolar electrode 104.
The monopolar electrode 104 can be connected to the monopolar blade 102 when the activation button for one or more modes is depressed. Because the monopolar electrode 104 can be in contact with the tissue while the monopolar blade 102 is active, the monopolar electrode 104 in one example is configured to be isolated from the full output voltage of the electrical surgical unit 10. Also, the controller 88 can be configured to make two separate contacts such as a contact with high voltage isolation for the monopolar electrode 104, and on a contact with low voltage isolation for the controller 88.
Accordingly, the controller 88 can provide a controlled make and break order of electrical connections with one or more pushbuttons 88a, 88b, and 88c. A traditional micro switch may not provide isolation and using dual micro switches even if one has adequate isolation may be applied in an incorrect order. To over come these challenges, the controller 88 can include a dome switch to provide isolation and order. The dome switch is used for the low voltage connection and is affixed to the circuit board of the controller 88 with an insulative tape, such as with a polyimide tape available under the trade designation Kapton from DuPont of Wilmington, Del. A hole is provided in the tape over the dome switch to expose metal underneath. A lever, such as a conductive spring, is positioned above the dome so that it strikes the exposed metal of the dome centered on the hole in the tape. This conductive lever is then electrically connected via the circuit board to the monopolar electrode 104. An insulated button top, such as one of push buttons 88a, 88b, 88c, is then placed over the lever and the dome in such a manner that when the user depresses the button top the lever is first pressed into contact with the top of the dome electrically connecting the monopolar electrode 104 to the monopolar blade 102. In one example, the low force of the lever provides no tactile feedback to the user upon the first press. When the button top is further depressed, however, the dome snaps and makes the second contact, providing tactile feedback, as well as connecting activation wires to deliver a monopolar signal to the electrode assembly 100. When the button top is released, this process is reversed and the electrosurgical unit 10 turns off before the electrode assembly 100 is disconnected.
While electrode assembly 100 is described with reference to electrosurgical surgical device 70 and other elements of system 60, it should understood the description of the combination is for the purposes of illustrating one example of an electrosurgical device 30 having electrode assembly 100. It may be possible to use the electrode assembly 100 in other electrosurgical devices or with other systems using other electrosurgical units.
Tail portion 110 in the example includes one or more electrical conductors, such as arms 114a, 144b, electrically coupled to the monopolar blade 102 and configured to be operably coupled to the controller 88 to provide cutting and coagulation RF energy to the monopolar blade 102 when activated. The tail portion 110 also includes hypotube 116 in fluid communication with fluid port 106 and tubing 16 for delivering fluid 12 to the active portion 112 and dispersing fluid 12 from the fluid port 106. In the example, hypotube 116 is electrically conductive or includes an electrically conductive portion such as a wire or trace that is operably coupled to electrode 104 and configured to be operably couple to the controller 88 to provide hemostatic sealing RF energy to the electrode 104 when activated. The hypotube 116 in the example is electrically isolated from the arms 114a, 114b. In one example, the arms 114a, 114b and hypotube 116 can be electrically coupled to the controller 88 using wires or other electrical leads in the shaft 94 or elsewhere in the electrosurgical device 70 via a spot weld or other connection so as to conduct electrical energy from the controller 88 to electrode assembly 100. Hypotube 116 and arms 114a, 114b are held spaced-apart from each other with the intermediate component 108.
The intermediate component 108 can be formed from an insulative material such as a high temperature micromolded polymer. Examples insulative materials can include polytetrafluoroethylene (PTFE), polycarbonate (PC), polyoxymethylene (POM or acetal), or polyether ether ketone (PEEK). Intermediate portion 108 includes first and second side surfaces 120a, 120b defining an edge 122 and an end 124. The example intermediate component 108 includes a rounded tip 126.
The monopolar electrode 104 can be formed from a conductive material such as stainless steel. In the example, the monopolar electrode 104 includes first and second major exposed conductive surfaces 160a, 160b, disposed on sides 120a, 120b, of the intermediate component 108. The major exposed conductive surfaces 160a, 160b are configured to engage tissue and bone and to deliver hemostatic sealing RF energy.
The distal end 150 of the hypotube 116 is fluidly coupled to the rod 164 at the fluid passage 166. For example, the fluid passage 166 includes an inlet 168 in fluid communication with the lumen 142 of the hypotube 116, and the fluid passage includes an outlet 169 in fluid communication with the fluid port 106 such that the lumen 142 is in fluid communication with the fluid port 106. Fluid 12 from the delivery tubing 16 is passed into the handpiece 80 and into the hypotube 116 and from the hypotube into the rod 164 where it is dispersed from the fluid port 106 on the major conductive exposed surfaces 160a, 160b.
Additionally, monopolar electrode 104 is electrically coupled to the distal end 150 of the hypotube 116 to receive hemostatic sealing RF energy from the controller 88. The major conductive exposed surfaces 160a, 160b have a relatively large surface area to provide a relatively low impedance and low current density for the hemostatic sealing RF energy.
In an example, the cutting blade 170 is formed from a conductive element 180 partially coated with an insulator 182 to expose a conductive cutting electrode 184 proximate the perimeter 176. By implementing the cutting electrode 184, the conductive element 180 and insulator 182 cooperate to form a sturdy, substantially sized cutting blade assembly having only a small fraction of the conductive surface area of a similarly sized fully exposed metal blade at the cutting electrode 184 to reduce the size of a thermal damage zone. Thus, the cutting blade 170 serves to harness and focus the monopolar energy allowing it to create plasma for precise dissection and coagulation with reduced power, a higher current density at the cutting electrode 184, or a combination of reduced power and higher current density than available in a similarly sized fully-exposed metal blade.
The conductive element 180 can be formed from a metal, such as stainless steel or titanium, and the insulator 182 can be formed of glass or ceramic. In one example, the conductive element 180 is formed from a ferritic and martensitic chromium alloy as in series 400 stainless steel, which also adheres well to a glass or ceramic coating. In one example, the conductive element 180 is series 420 stainless steel. The conductive element 180 can be machined, stamped, or etched out of a larger sheet of metal. The conductive element 180 can be honed to a sharp, tapered blade edge 174 on one or both sides 172a, 172b. In one example, the exposed conductive cutting electrode 184 includes a thickness of between about 1 micrometer and 100 micrometers. In some examples, the conductive element 180 can be coated with a glass or ceramic insulator 182, such as a glass enamel insulator 182, by dipping the conductive element 180 in liquid or molten glass and then annealing the glass prior to assembly. In one example, the insulator 182 has a thickness of between about half and three times the thickness of the exposed conductive cutting electrode 184. In one example, the width of the cutting blade 170 of monopolar blade 102, as measured in a direction from tail 114a to tail 114b, is more than twice the diameter of the major surfaces 160a, 160b of the monopolar blade 104.
In the illustrated example, the monopolar blade 102 includes a single conductive element 180 configured as the cutting blade 178. In some examples, however, the monopolar blade 102 can be formed of multiple pieces of conductive material and include separate electrodes that provide cut and coagulation functions, respectively, such as described in U.S. Pat. No. 8,414,572 to Davidson, et al., assigned to the assignee of the present disclosure and incorporated by reference herein in its entireties to the extent it is not inconsistent with the present disclosure.
In the example, the proximal conductive terminal 194, distal conductive terminal 196, and conductive element 198 are configured from a conductive stainless steel. The proximal conductive terminal 194 can be configured to form a hollow barb-like fitting on tubing 192 that can mate with tubing 16, such as commonly used flexible tubing 16, such as polyvinyl chloride (PVC) tubing 16, to supply fluid 12 to the electrosurgical device 70 or electrode assembly 100. The distal conductive terminal 196 can be configured as a cylindrical tube partially disposed within tube 192 having a distally extending end coupled to the rod 164. The proximal conductive terminal 194 is electrically coupleable to the controller and the distal conductive terminal 196 is electrically coupleable to the rod 164 at inlet 168.
The tube 192 can be constructed from a non-conductive material such as PVC, PEEK, or a thermoplastic elastomer (TPE). In one example, the TPE is a polyether block amide (PEBA) available under the trade designation PEBAX from Arkema of Colombes, France. The conductive element 198 can be formed in the wall or tube 192 or can extend within the lumen of the tube 192 from the proximal conductive element 194 to the distal conductive element 196, such as a wire within the lumen.
In some examples, the hypotube 200 can be formed from a stock piece of PEBA tubing. The length of the segments 202, 204, 206 can be selected by reference to dimensions of the electrosurgical device 70 including the length to fully extend and fully collapse. The time and temperature to shape and set the tubing can be selected based on various factors such as overall dimensions of the tubing, material used, stiffness of the coil desired, the propensity of the coil to lose shape after repeated extensions.
In one example of manufacturing electrode assembly 100, the monopolar blade 102, monopolar electrode 104, and hypotube 116 can be formed in separate processes and joined together. The hypotube 116 and monopolar electrode 104 can be welded together. The hypotube 116 joined with the monopolar electrode 104 can be overmolded with an electrically insulative material to form the intermediate component 108. The monopolar blade 102 can be attached to the intermediate component 108. The electrode assembly can be electrically coupled to a handpiece 80 and attached to the shaft 94. In one example, the electrode assembly can be attached to the shaft and handpiece of an electrosurgical device such as those sold under the trade designations PEAK PlasmaBlade 3.0, Peak PlasmaBlade 4.0, or similar products available from Medtronic Advanced Energy, LLC, of Minneapolis, Minn.
Although the present disclosure has been described with reference to preferred embodiments, workers skilled in the art will recognize that changes can be made in form and detail without departing from the spirit and scope of the present disclosure.
This Non-Provisional Utility Application claims benefit to U.S. Provisional Application No. 62/269,235, filed Dec. 18, 2015, titled “ELECTROSURGICAL DEVICE WITH MONOPOLAR ELECTRODE ASSEMBLY” the entirety of which incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2888928 | Seiger | Apr 1957 | A |
3223088 | Barber et al. | Dec 1965 | A |
3682130 | Jeffers | Aug 1972 | A |
3750650 | Ruttgers | Aug 1973 | A |
3955284 | Balson | May 1976 | A |
4014342 | Staub et al. | Mar 1977 | A |
4195637 | Gruntzig et al. | Apr 1980 | A |
4207897 | Loyd et al. | Jun 1980 | A |
4244371 | Farin | Jan 1981 | A |
4248224 | Jones | Feb 1981 | A |
4275734 | Mitchiner | Jun 1981 | A |
4276874 | Wolvek et al. | Jul 1981 | A |
4278090 | Van Gerven | Jul 1981 | A |
4321931 | Hon | Mar 1982 | A |
4342218 | Fox | Aug 1982 | A |
4355642 | Alfemess | Oct 1982 | A |
4377168 | Rzasa et al. | Mar 1983 | A |
4381007 | Doss | Apr 1983 | A |
4519389 | Gudkin et al. | May 1985 | A |
4598698 | Siegmund | Jul 1986 | A |
4601290 | Effron et al. | Jul 1986 | A |
4664110 | Schanzlin | May 1987 | A |
4671274 | Scrochenko | Jun 1987 | A |
4708126 | Toda et al. | Nov 1987 | A |
4736749 | Lundback | Apr 1988 | A |
4779611 | Grooters et al. | Oct 1988 | A |
4802475 | Weshahy | Feb 1989 | A |
4878493 | Pasternak et al. | Nov 1989 | A |
4919129 | Weber et al. | Apr 1990 | A |
4931047 | Broadwin et al. | Jun 1990 | A |
4932952 | Wojciechowicz, Jr. | Jun 1990 | A |
4943290 | Rexroth et al. | Jul 1990 | A |
4950232 | Ruzicka et al. | Aug 1990 | A |
4985030 | Melzer et al. | Jan 1991 | A |
4998933 | Eggers et al. | Mar 1991 | A |
5112299 | Pascaloff | May 1992 | A |
5167659 | Ohtomo et al. | Dec 1992 | A |
5190541 | Abele et al. | Mar 1993 | A |
5195959 | Smith | Mar 1993 | A |
5230704 | Moberg et al. | Jul 1993 | A |
5234428 | Kaufman | Aug 1993 | A |
5254117 | Rigby et al. | Oct 1993 | A |
5275609 | Pingleton et al. | Jan 1994 | A |
5281215 | Midler | Jan 1994 | A |
5309896 | Moll et al. | May 1994 | A |
5316000 | Chapelon et al. | May 1994 | A |
5317878 | Bradshaw et al. | Jun 1994 | A |
5318525 | West et al. | Jun 1994 | A |
5322520 | Milder | Jun 1994 | A |
5323781 | Ideker et al. | Jun 1994 | A |
5324255 | Passafaro et al. | Jun 1994 | A |
5324284 | Imran | Jun 1994 | A |
5324286 | Fowler | Jun 1994 | A |
5330521 | Cohen | Jul 1994 | A |
5334181 | Rubinsky et al. | Aug 1994 | A |
5334193 | Nardella | Aug 1994 | A |
5336220 | Ryan et al. | Aug 1994 | A |
5348554 | Imran et al. | Sep 1994 | A |
5352222 | Rydell et al. | Oct 1994 | A |
5353783 | Nakao et al. | Oct 1994 | A |
5354258 | Dory | Oct 1994 | A |
5361752 | Moll et al. | Nov 1994 | A |
5376078 | Dinger et al. | Dec 1994 | A |
5383874 | Jackson et al. | Jan 1995 | A |
5385148 | Lesh et al. | Jan 1995 | A |
5395312 | Desai | Mar 1995 | A |
5396887 | Imran | Mar 1995 | A |
5397304 | Truckai | Mar 1995 | A |
5400770 | Nakao et al. | Mar 1995 | A |
5400783 | Pomeranz et al. | Mar 1995 | A |
5401272 | Perkins | Mar 1995 | A |
5403309 | Coleman et al. | Apr 1995 | A |
5403311 | Abele et al. | Apr 1995 | A |
5405348 | Anspach et al. | Apr 1995 | A |
5405376 | Mulier et al. | Apr 1995 | A |
5409483 | Campbell et al. | Apr 1995 | A |
5413556 | Whittingham | May 1995 | A |
5417709 | Slater | May 1995 | A |
5423807 | Mlilder | Jun 1995 | A |
5423811 | Imran et al. | Jun 1995 | A |
5427119 | Swartz et al. | Jun 1995 | A |
5431168 | Webster, Jr. | Jul 1995 | A |
5431649 | Mulier et al. | Jul 1995 | A |
5433708 | Nichols et al. | Jul 1995 | A |
5435308 | Gallup et al. | Jul 1995 | A |
5437651 | Todd et al. | Aug 1995 | A |
5441503 | Considine et al. | Aug 1995 | A |
5443463 | Stem et al. | Aug 1995 | A |
5443470 | Stem et al. | Aug 1995 | A |
5445638 | Rydell et al. | Aug 1995 | A |
5450843 | Moll et al. | Sep 1995 | A |
5452582 | Longsworth | Sep 1995 | A |
5452733 | Sterman et al. | Sep 1995 | A |
5460629 | Shlain et al. | Oct 1995 | A |
5462545 | Wang et al. | Oct 1995 | A |
5465717 | Imran et al. | Nov 1995 | A |
5469853 | Law et al. | Nov 1995 | A |
5472876 | Fahy | Dec 1995 | A |
5478309 | Sweezer et al. | Dec 1995 | A |
5478330 | Imran et al. | Dec 1995 | A |
5486193 | Bourne et al. | Jan 1996 | A |
5487385 | Avitall | Jan 1996 | A |
5487757 | Truckai et al. | Jan 1996 | A |
5490819 | Nicholas et al. | Feb 1996 | A |
5492527 | Glowa et al. | Feb 1996 | A |
5496271 | Burton et al. | Mar 1996 | A |
5496312 | Klicek | Mar 1996 | A |
5497774 | Swartz et al. | Mar 1996 | A |
5498248 | Milder | Mar 1996 | A |
5500012 | Brucker et al. | Mar 1996 | A |
5505500 | Webb et al. | Apr 1996 | A |
5505730 | Edwards | Apr 1996 | A |
5516505 | McDow | May 1996 | A |
5520682 | Baust et al. | May 1996 | A |
5522870 | Ben-Zion | Jun 1996 | A |
5536267 | Edwards et al. | Jul 1996 | A |
5540562 | Giter | Jul 1996 | A |
5540708 | Lim et al. | Jul 1996 | A |
5542196 | Hirsch et al. | Aug 1996 | A |
5542945 | Fritzsch | Aug 1996 | A |
5545195 | Lennox et al. | Aug 1996 | A |
5545200 | West et al. | Aug 1996 | A |
5549661 | Kordis et al. | Aug 1996 | A |
5555883 | Avitall | Sep 1996 | A |
5556397 | Long et al. | Sep 1996 | A |
5558671 | Yates | Sep 1996 | A |
5560362 | Sliwa, Jr. et al. | Oct 1996 | A |
5560373 | DeSantis | Oct 1996 | A |
5562702 | Huitema et al. | Oct 1996 | A |
5562720 | Stem et al. | Oct 1996 | A |
5569241 | Edwards | Oct 1996 | A |
5569243 | Kortenbach et al. | Oct 1996 | A |
5569254 | Carlson et al. | Oct 1996 | A |
5571088 | Lennox et al. | Nov 1996 | A |
5571215 | Sterman et al. | Nov 1996 | A |
5573424 | Poppe | Nov 1996 | A |
5573532 | Chang et al. | Nov 1996 | A |
5575766 | Swartz et al. | Nov 1996 | A |
5575788 | Baker et al. | Nov 1996 | A |
5575810 | Swanson et al. | Nov 1996 | A |
5578007 | Imran | Nov 1996 | A |
5582609 | Swanson et al. | Dec 1996 | A |
5588432 | Crowley | Dec 1996 | A |
5590657 | Cain et al. | Jan 1997 | A |
5595183 | Swanson et al. | Jan 1997 | A |
5599346 | Edwards et al. | Feb 1997 | A |
5605539 | Buelna et al. | Feb 1997 | A |
5607462 | Imran | Mar 1997 | A |
5609573 | Sandock | Mar 1997 | A |
5617854 | Munsif | Apr 1997 | A |
5620415 | Lucey et al. | Apr 1997 | A |
5620447 | Smith et al. | Apr 1997 | A |
5630837 | Crowley | May 1997 | A |
5643197 | Brucker et al. | Jul 1997 | A |
5647869 | Goble et al. | Jul 1997 | A |
5656029 | Imran et al. | Aug 1997 | A |
5658278 | Imran et al. | Aug 1997 | A |
5637090 | McGee et al. | Sep 1997 | A |
5671747 | Connor | Sep 1997 | A |
5672153 | Lax | Sep 1997 | A |
5673695 | McGee et al. | Oct 1997 | A |
5676662 | Fleischhacker et al. | Oct 1997 | A |
5676692 | Sanghvi et al. | Oct 1997 | A |
5676693 | Lafontaine | Oct 1997 | A |
5678550 | Bassen et al. | Oct 1997 | A |
5680860 | Imran | Oct 1997 | A |
5681278 | Igo et al. | Oct 1997 | A |
5681294 | Osborne et al. | Oct 1997 | A |
5681308 | Edwards et al. | Oct 1997 | A |
5687723 | Avitall | Nov 1997 | A |
5687737 | Branham et al. | Nov 1997 | A |
5688267 | Panescu et al. | Nov 1997 | A |
5690611 | Swartz et al. | Nov 1997 | A |
5697536 | Eggers et al. | Dec 1997 | A |
5697882 | Eggers et al. | Dec 1997 | A |
5697925 | Taylor | Dec 1997 | A |
5697927 | Imran et al. | Dec 1997 | A |
5697928 | Walcott et al. | Dec 1997 | A |
5700262 | Acosta | Dec 1997 | A |
5702390 | Austin et al. | Dec 1997 | A |
5712543 | Sjostrom | Jan 1998 | A |
5713942 | Stem | Feb 1998 | A |
5716389 | Walinsky et al. | Feb 1998 | A |
5718241 | Ben-Haim et al. | Feb 1998 | A |
5718701 | Shai et al. | Feb 1998 | A |
5720775 | Lanard | Feb 1998 | A |
5722402 | Swanson et al. | Mar 1998 | A |
5730074 | Peter | Mar 1998 | A |
5730127 | Avitall | Mar 1998 | A |
5730704 | Avitall | Mar 1998 | A |
5733280 | Avitall | Mar 1998 | A |
5735280 | Sherman et al. | Apr 1998 | A |
5743903 | Stem et al. | Apr 1998 | A |
5755760 | Maguire et al. | May 1998 | A |
5766167 | Eggers et al. | Jun 1998 | A |
5769846 | Edwards et al. | Jun 1998 | A |
5782828 | Chen et al. | Jul 1998 | A |
5785706 | Bednarek | Jul 1998 | A |
5788636 | Curley | Aug 1998 | A |
5792140 | Tu et al. | Aug 1998 | A |
5792167 | Kablik et al. | Aug 1998 | A |
5797905 | Fleischman et al. | Aug 1998 | A |
5797960 | Stevens et al. | Aug 1998 | A |
5735290 | Nelson et al. | Sep 1998 | A |
5800428 | Nelson et al. | Sep 1998 | A |
5800482 | Pomeranz et al. | Sep 1998 | A |
5810764 | Eggers et al. | Sep 1998 | A |
5810802 | Panescu et al. | Sep 1998 | A |
5810809 | Rydell | Sep 1998 | A |
5814044 | Hooven | Sep 1998 | A |
5827216 | Igo et al. | Oct 1998 | A |
5836947 | Fleischman et al. | Nov 1998 | A |
5840030 | Ferek-Petric et al. | Nov 1998 | A |
5843021 | Edwards et al. | Dec 1998 | A |
5843152 | Tu et al. | Dec 1998 | A |
5844349 | Oakley et al. | Dec 1998 | A |
5846187 | Wells et al. | Dec 1998 | A |
5846191 | Wells et al. | Dec 1998 | A |
5849023 | Mericle | Dec 1998 | A |
5849028 | Chen | Dec 1998 | A |
5861021 | Thome et al. | Jan 1999 | A |
5871523 | Fleischman et al. | Feb 1999 | A |
5871525 | Edwards et al. | Feb 1999 | A |
5873845 | Cline et al. | Feb 1999 | A |
5873855 | Eggers et al. | Feb 1999 | A |
5873886 | Larsen et al. | Feb 1999 | A |
5876399 | Chia et al. | Mar 1999 | A |
5879295 | Li et al. | Mar 1999 | A |
5879296 | Ockuly et al. | Mar 1999 | A |
5879348 | Owens et al. | Mar 1999 | A |
5881732 | Sung et al. | Mar 1999 | A |
5882346 | Pomeranz et al. | Mar 1999 | A |
5885278 | Fleischman | Mar 1999 | A |
5891142 | Eggers et al. | Apr 1999 | A |
5893848 | Negus et al. | Apr 1999 | A |
5895355 | Schaer | Apr 1999 | A |
5895417 | Pomeranz et al. | Apr 1999 | A |
5897553 | Mulier | Apr 1999 | A |
5897554 | Chia et al. | Apr 1999 | A |
5899898 | Arless et al. | May 1999 | A |
5899899 | Arless et al. | May 1999 | A |
5899915 | Saadat | May 1999 | A |
5902289 | Swartz et al. | May 1999 | A |
5904681 | West, Jr. | May 1999 | A |
5904711 | Flom et al. | May 1999 | A |
5906580 | Kline-Schoder et al. | May 1999 | A |
5906587 | Zimmon | May 1999 | A |
5906606 | Chee et al. | May 1999 | A |
5908029 | Knudson et al. | Jun 1999 | A |
5913854 | Maguire et al. | Jun 1999 | A |
5916213 | Haissaguerre et al. | Jun 1999 | A |
5916214 | Cosio et al. | Jun 1999 | A |
5921924 | Avitall | Jul 1999 | A |
5921982 | Lesh et al. | Jul 1999 | A |
5925045 | Reimels et al. | Jul 1999 | A |
5927284 | Borst et al. | Jul 1999 | A |
5931810 | Grabek | Aug 1999 | A |
5931848 | Saadat | Aug 1999 | A |
5935123 | Edwards et al. | Aug 1999 | A |
5944715 | Goble et al. | Aug 1999 | A |
5928191 | Houser et al. | Sep 1999 | A |
5954661 | Greenspon et al. | Sep 1999 | A |
5954686 | Garito | Sep 1999 | A |
5975919 | Laufer | Sep 1999 | A |
5971980 | Sherman | Oct 1999 | A |
5971983 | Lesh | Oct 1999 | A |
5980516 | Mulier et al. | Nov 1999 | A |
5989248 | Tu et al. | Nov 1999 | A |
5993412 | Deily et al. | Nov 1999 | A |
5993447 | Blewett et al. | Nov 1999 | A |
6004316 | Laufer | Dec 1999 | A |
6004319 | Goble et al. | Dec 1999 | A |
6007499 | Martin et al. | Dec 1999 | A |
6010500 | Sherman et al. | Jan 2000 | A |
6012457 | Lesh | Jan 2000 | A |
6015391 | Rishton et al. | Jan 2000 | A |
6016811 | Knopp et al. | Jan 2000 | A |
6018676 | Davis et al. | Jan 2000 | A |
6019757 | Scheldrup | Feb 2000 | A |
6024733 | Eggers et al. | Feb 2000 | A |
6030381 | Jones et al. | Feb 2000 | A |
6036687 | Laufer et al. | Mar 2000 | A |
6042556 | Beach et al. | Mar 2000 | A |
6042593 | Storz et al. | Mar 2000 | A |
6048333 | Lennox et al. | Apr 2000 | A |
6053923 | Veca et al. | Apr 2000 | A |
6056744 | Edwards | May 2000 | A |
6056745 | Panescu et al. | May 2000 | A |
6056746 | Goble | May 2000 | A |
6056747 | Saadat et al. | May 2000 | A |
6066139 | Ryan et al. | May 2000 | A |
6068653 | LaFontaine | May 2000 | A |
6083237 | Huitema et al. | Jul 2000 | A |
6086585 | Hovda et al. | Jul 2000 | A |
6113596 | Hooven et al. | Sep 2000 | A |
6117101 | Diederich et al. | Sep 2000 | A |
6120496 | Whayne et al. | Sep 2000 | A |
6141576 | Littmann et al. | Oct 2000 | A |
6142993 | Whayne et al. | Nov 2000 | A |
6142994 | Swanson et al. | Nov 2000 | A |
6149620 | Baker et al. | Nov 2000 | A |
6152920 | Thompson et al. | Nov 2000 | A |
6161543 | Cox et al. | Dec 2000 | A |
6165174 | Jacobs et al. | Dec 2000 | A |
6190384 | Ouchi | Feb 2001 | B1 |
6193716 | Shannon, Jr. | Feb 2001 | B1 |
6210406 | Webster | Apr 2001 | B1 |
6210410 | Farin et al. | Apr 2001 | B1 |
6210411 | Hofmann et al. | Apr 2001 | B1 |
6212426 | Swanson | Apr 2001 | B1 |
6224592 | Eggers et al. | May 2001 | B1 |
6231518 | Grabek et al. | May 2001 | B1 |
6231591 | Desai | May 2001 | B1 |
6235020 | Cheng et al. | May 2001 | B1 |
6237605 | Vaska et al. | May 2001 | B1 |
6238347 | Nix et al. | May 2001 | B1 |
6238387 | Miller, III | May 2001 | B1 |
6238393 | Mulier | May 2001 | B1 |
6245061 | Panescu et al. | Jun 2001 | B1 |
6245064 | Lesh et al. | Jun 2001 | B1 |
6245065 | Panescu et al. | Jun 2001 | B1 |
6251092 | Qin et al. | Jun 2001 | B1 |
6251110 | Wampler | Jun 2001 | B1 |
6251128 | Knopp et al. | Jun 2001 | B1 |
6258087 | Edwards et al. | Jul 2001 | B1 |
6264650 | Hovda et al. | Jul 2001 | B1 |
6266551 | Osadchy et al. | Jul 2001 | B1 |
6283988 | Laufer et al. | Sep 2001 | B1 |
6283989 | Laufer et al. | Sep 2001 | B1 |
6296638 | Davison et al. | Oct 2001 | B1 |
6299633 | Laufer | Oct 2001 | B1 |
6311692 | Vaska et al. | Nov 2001 | B1 |
6312383 | Lizzi et al. | Nov 2001 | B1 |
6314962 | Vaska et al. | Nov 2001 | B1 |
6314963 | Vaska et al. | Nov 2001 | B1 |
6322559 | Daulton et al. | Nov 2001 | B1 |
6325797 | Stewart et al. | Dec 2001 | B1 |
6328735 | Curley et al. | Dec 2001 | B1 |
6328736 | Mulier | Dec 2001 | B1 |
6332881 | Carner et al. | Dec 2001 | B1 |
6352533 | Ellman et al. | Mar 2002 | B1 |
6358248 | Mulier | Mar 2002 | B1 |
6361531 | Hissong | Mar 2002 | B1 |
6364876 | Erb et al. | Apr 2002 | B1 |
6368275 | Sliwa et al. | Apr 2002 | B1 |
6371955 | Fuimaono et al. | Apr 2002 | B1 |
6371956 | Wilson et al. | Apr 2002 | B1 |
6383151 | Diederich et al. | May 2002 | B1 |
6385472 | Hall et al. | May 2002 | B1 |
6398792 | O'Connor | Jun 2002 | B1 |
6409722 | Hoey | Jun 2002 | B1 |
6413254 | Hissong et al. | Jul 2002 | B1 |
6416509 | Goble et al. | Jul 2002 | B1 |
6425867 | Vaezy et al. | Jul 2002 | B1 |
6430426 | Avitall | Aug 2002 | B2 |
6440130 | Mulier | Aug 2002 | B1 |
6443952 | Mulier | Sep 2002 | B1 |
6447507 | Bednarek et al. | Sep 2002 | B1 |
6461314 | Pant et al. | Oct 2002 | B1 |
6461956 | Patterson | Oct 2002 | B1 |
6464700 | Koblish et al. | Oct 2002 | B1 |
6471697 | Lesh | Oct 2002 | B1 |
6471698 | Edwards et al. | Oct 2002 | B1 |
6474340 | Vaska et al. | Nov 2002 | B1 |
6475216 | Mulier | Nov 2002 | B2 |
6477396 | Mest et al. | Nov 2002 | B1 |
6478793 | Cosman et al. | Nov 2002 | B1 |
6484727 | Vaska et al. | Nov 2002 | B1 |
6488678 | Sherman | Dec 2002 | B2 |
6488680 | Francischelli | Dec 2002 | B1 |
6494892 | Ireland et al. | Dec 2002 | B1 |
6497704 | Ein-Gal | Dec 2002 | B2 |
6502575 | Jacobs et al. | Jan 2003 | B1 |
6508815 | Strul et al. | Jan 2003 | B1 |
6517536 | Hooven et al. | Feb 2003 | B2 |
6537248 | Mulier | Mar 2003 | B2 |
6537272 | Hoey | Mar 2003 | B2 |
6558382 | Jahns | May 2003 | B2 |
6558385 | Bloom et al. | May 2003 | B1 |
6575969 | Rittman, III et al. | Jun 2003 | B1 |
6579288 | Swanson et al. | Jun 2003 | B1 |
6585732 | Mulier | Jul 2003 | B2 |
6602248 | Sharps et al. | Aug 2003 | B1 |
6603988 | Dowlatshahi | Aug 2003 | B2 |
6610055 | Swanson et al. | Aug 2003 | B1 |
6610060 | Mulier | Aug 2003 | B2 |
6613048 | Mulier | Sep 2003 | B2 |
6635034 | Cosmescu | Oct 2003 | B1 |
6645199 | Jenkins et al. | Nov 2003 | B1 |
6645202 | Pless et al. | Nov 2003 | B1 |
6648883 | Francischelli | Nov 2003 | B2 |
6656175 | Francischelli | Dec 2003 | B2 |
6663627 | Francischelli | Dec 2003 | B2 |
6666862 | Jain et al. | Dec 2003 | B2 |
6679882 | Komerup | Jan 2004 | B1 |
6682501 | Nelson | Jan 2004 | B1 |
6689131 | McClurken | Feb 2004 | B2 |
6702810 | McClurken et al. | Mar 2004 | B2 |
6706038 | Francischelli | Mar 2004 | B2 |
6706039 | Mulier | Mar 2004 | B2 |
6716211 | Mulier | Apr 2004 | B2 |
6716215 | David et al. | Apr 2004 | B1 |
6736810 | Hoey | May 2004 | B2 |
6752816 | Culp et al. | Jun 2004 | B2 |
6755827 | Mulier | Jun 2004 | B2 |
6764487 | Mulier | Jul 2004 | B2 |
6766817 | da Silva | Jul 2004 | B2 |
6775575 | Bommannan et al. | Aug 2004 | B2 |
6776780 | Mulier | Aug 2004 | B2 |
6786906 | Cobb | Sep 2004 | B1 |
6807968 | Francischelli | Oct 2004 | B2 |
6827713 | Bek et al. | Dec 2004 | B2 |
6827715 | Francischelli | Dec 2004 | B2 |
6832996 | Woloszko et al. | Dec 2004 | B2 |
6849073 | Hoey | Feb 2005 | B2 |
6858028 | Mulier | Feb 2005 | B2 |
6887238 | Jahns | May 2005 | B2 |
6899711 | Stewart et al. | May 2005 | B2 |
6911019 | Mulier | Jun 2005 | B2 |
6915806 | Pacek et al. | Jul 2005 | B2 |
6916318 | Francischelli | Jul 2005 | B2 |
6918404 | Dias da Silva | Jul 2005 | B2 |
6936046 | Hissong | Aug 2005 | B2 |
6942661 | Swanson | Sep 2005 | B2 |
6949097 | Stewart et al. | Sep 2005 | B2 |
6949098 | Mulier | Sep 2005 | B2 |
6953461 | Bloom et al. | Oct 2005 | B2 |
6960205 | Jahns | Nov 2005 | B2 |
6962589 | Mulier | Nov 2005 | B2 |
6979332 | Adams | Dec 2005 | B2 |
7018241 | Caveney et al. | Mar 2006 | B2 |
7048687 | Reuss et al. | May 2006 | B1 |
7066586 | da Silva | Jun 2006 | B2 |
7156845 | Mulier et al. | Jan 2007 | B2 |
7166106 | Bartel et al. | Jan 2007 | B2 |
7179255 | Lettice et al. | Feb 2007 | B2 |
7207471 | Heinrich et al. | Apr 2007 | B2 |
7232440 | Dumbauld et al. | Jun 2007 | B2 |
7237990 | Deng | Jul 2007 | B2 |
7247155 | Hoey et al. | Jul 2007 | B2 |
7247161 | Johnston et al. | Jul 2007 | B2 |
7261711 | Mulier et al. | Aug 2007 | B2 |
7276074 | Adams et al. | Oct 2007 | B2 |
7309325 | Mulier et al. | Dec 2007 | B2 |
7311708 | McClurken | Dec 2007 | B2 |
7322974 | Swoyer et al. | Jan 2008 | B2 |
7361175 | Suslov | Apr 2008 | B2 |
7364579 | Mulier et al. | Apr 2008 | B2 |
7445436 | Mittelstein et al. | Nov 2008 | B2 |
7537595 | McClurken | May 2009 | B2 |
7604635 | Bloom et al. | Oct 2009 | B2 |
7645277 | Bloom et al. | Jan 2010 | B2 |
7651494 | Bloom et al. | Jan 2010 | B2 |
7736361 | Palanker et al. | Jun 2010 | B2 |
7776014 | Visconti et al. | Aug 2010 | B2 |
7815634 | Bloom et al. | Oct 2010 | B2 |
7909820 | Lipson et al. | Mar 2011 | B2 |
7918852 | Tullis et al. | Apr 2011 | B2 |
7942872 | Ein-Gal | May 2011 | B2 |
7976544 | McClurken et al. | Jul 2011 | B2 |
7993337 | Lesh | Aug 2011 | B2 |
7997278 | Utley et al. | Aug 2011 | B2 |
7998140 | McClurken | Aug 2011 | B2 |
8034071 | Scribner et al. | Oct 2011 | B2 |
8038670 | McClurken | Oct 2011 | B2 |
8048070 | O'Brien et al. | Nov 2011 | B2 |
8083736 | Bloom et al. | Dec 2011 | B2 |
8109956 | Shadeck | Feb 2012 | B2 |
8172828 | Chang et al. | Apr 2012 | B2 |
8177783 | Davison et al. | May 2012 | B2 |
8202288 | Adams et al. | Jun 2012 | B2 |
8216233 | McClurken et al. | Jul 2012 | B2 |
8323276 | Palanker et al. | Dec 2012 | B2 |
8348946 | McClurken et al. | Jan 2013 | B2 |
8361068 | McClurken | Jan 2013 | B2 |
8388642 | Munietal | Mar 2013 | B2 |
8414572 | Davison et al. | Apr 2013 | B2 |
8475455 | McClurken et al. | Jul 2013 | B2 |
8562598 | Falkenstein et al. | Oct 2013 | B2 |
8568409 | O'Brien et al. | Oct 2013 | B2 |
8632533 | Greeley et al. | Jan 2014 | B2 |
8882756 | Greeley et al. | Nov 2014 | B2 |
8906012 | Conley et al. | Dec 2014 | B2 |
8920417 | Conley et al. | Dec 2014 | B2 |
8979842 | McNall, III et al. | Mar 2015 | B2 |
8992524 | Ellman | Mar 2015 | B1 |
20010032002 | McClurken et al. | Oct 2001 | A1 |
20010047183 | Privitera et al. | Nov 2001 | A1 |
20020038129 | Peters et al. | Mar 2002 | A1 |
20020049483 | Knowlton | Apr 2002 | A1 |
20020062131 | Gallo, Sr. | May 2002 | A1 |
20020082643 | Kammerer et al. | Jun 2002 | A1 |
20020165541 | Whitman | Nov 2002 | A1 |
20020198519 | Qin et al. | Dec 2002 | A1 |
20030014050 | Sharkey et al. | Jan 2003 | A1 |
20030032954 | Carranza et al. | Feb 2003 | A1 |
20030045872 | Jacobs | Mar 2003 | A1 |
20030073993 | Ciarrocca | Apr 2003 | A1 |
20030097129 | Davison et al. | May 2003 | A1 |
20030144656 | Ocel | Jul 2003 | A1 |
20030191462 | Jacobs | Oct 2003 | A1 |
20030204185 | Sherman et al. | Oct 2003 | A1 |
20030216724 | Jahns | Nov 2003 | A1 |
20040015106 | Coleman | Jan 2004 | A1 |
20040015219 | Francischelli | Jan 2004 | A1 |
20040024395 | Ellman et al. | Feb 2004 | A1 |
20040044340 | Francischelli | Mar 2004 | A1 |
20040049179 | Francischelli | Mar 2004 | A1 |
20040078069 | Francischelli | Apr 2004 | A1 |
20040082948 | Stewart et al. | Apr 2004 | A1 |
20040087940 | Jahns | May 2004 | A1 |
20040111136 | Sharkey et al. | Jun 2004 | A1 |
20040111137 | Sharkey et al. | Jun 2004 | A1 |
20040116923 | Desinger | Jun 2004 | A1 |
20040138621 | Jahns | Jul 2004 | A1 |
20040138656 | Francischelli | Jul 2004 | A1 |
20040143260 | Francischelli | Jul 2004 | A1 |
20040186465 | Francischelli | Sep 2004 | A1 |
20040204679 | Visconti et al. | Oct 2004 | A1 |
20040215183 | Hoey | Oct 2004 | A1 |
20040220560 | Briscoe | Nov 2004 | A1 |
20040236322 | Mulier | Nov 2004 | A1 |
20040243163 | Casiano et al. | Dec 2004 | A1 |
20040267326 | Ocel | Dec 2004 | A1 |
20050010095 | Stewart et al. | Jan 2005 | A1 |
20050037672 | Caveney et al. | Feb 2005 | A1 |
20050069437 | Mittelstein et al. | Mar 2005 | A1 |
20050090815 | Francischelli | Apr 2005 | A1 |
20050090816 | McClurken et al. | Apr 2005 | A1 |
20050143729 | Francischelli | Jun 2005 | A1 |
20050171525 | Rioux et al. | Aug 2005 | A1 |
20050209564 | Bonner | Sep 2005 | A1 |
20050222566 | Nakahira | Oct 2005 | A1 |
20050267454 | Hissong | Dec 2005 | A1 |
20050277970 | Norman et al. | Dec 2005 | A1 |
20060009756 | Francischelli | Jan 2006 | A1 |
20060009759 | Christian | Jan 2006 | A1 |
20060064085 | Schechter et al. | Mar 2006 | A1 |
20060106375 | Werneth et al. | May 2006 | A1 |
20060149225 | McClurken | Jul 2006 | A1 |
20070016185 | Tullis et al. | Jan 2007 | A1 |
20070049920 | Bloom et al. | Mar 2007 | A1 |
20070093808 | Mulier et al. | Apr 2007 | A1 |
20070112343 | Mische et al. | May 2007 | A1 |
20070118114 | Miller et al. | May 2007 | A1 |
20070149965 | Gallo, Sr. et al. | Jun 2007 | A1 |
20070156127 | Rioux et al. | Jul 2007 | A1 |
20070208332 | Mulier et al. | Sep 2007 | A1 |
20080004656 | Livneh | Jan 2008 | A1 |
20080015563 | Hoey et al. | Jan 2008 | A1 |
20080058796 | O'Brien et al. | Mar 2008 | A1 |
20080071270 | Desinger et al. | Mar 2008 | A1 |
20080103494 | Rioux et al. | May 2008 | A1 |
20080146918 | Magnin | Jun 2008 | A1 |
20080207208 | Schutz | Aug 2008 | A1 |
20080234673 | Marion | Sep 2008 | A1 |
20080262489 | Steinke | Oct 2008 | A1 |
20090222001 | Greeley et al. | Sep 2009 | A1 |
20090264879 | Bloom et al. | Oct 2009 | A1 |
20090270896 | Sullivan et al. | Oct 2009 | A1 |
20090306655 | Stangenes | Dec 2009 | A1 |
20100069904 | Cunningham | Mar 2010 | A1 |
20100100095 | Bloom et al. | Apr 2010 | A1 |
20100160906 | Jarrard | Jun 2010 | A1 |
20100168743 | Stone et al. | Jul 2010 | A1 |
20100204560 | Salahieh et al. | Aug 2010 | A1 |
20100217255 | Greeley et al. | Aug 2010 | A1 |
20100241178 | Tilson et al. | Sep 2010 | A1 |
20100298763 | Adams et al. | Nov 2010 | A1 |
20110009856 | Jorgensen et al. | Jan 2011 | A1 |
20110028965 | McClurken | Feb 2011 | A1 |
20110118772 | Chen | May 2011 | A1 |
20110137298 | Nguyen et al. | Jun 2011 | A1 |
20110178515 | Bloom et al. | Jul 2011 | A1 |
20110190762 | Benn et al. | Aug 2011 | A1 |
20110196367 | Gallo | Aug 2011 | A1 |
20110224669 | Podany | Sep 2011 | A1 |
20110295249 | Bloom et al. | Dec 2011 | A1 |
20110301578 | Muniz-Medina et al. | Dec 2011 | A1 |
20110319889 | Conley et al. | Dec 2011 | A1 |
20120004657 | Conley et al. | Jan 2012 | A1 |
20120221035 | Harvey | Feb 2012 | A1 |
20120071712 | Manwaring et al. | Mar 2012 | A1 |
20120095461 | Herscher et al. | Apr 2012 | A1 |
20120101496 | McClurken et al. | Apr 2012 | A1 |
20120116397 | Rencher et al. | May 2012 | A1 |
20120143293 | Mauch et al. | Jun 2012 | A1 |
20120151165 | Conley et al. | Jun 2012 | A1 |
20120157989 | Stone et al. | Jun 2012 | A1 |
20120184983 | Chang et al. | Jul 2012 | A1 |
20120191084 | Davison | Jul 2012 | A1 |
20120191117 | Palmer et al. | Jul 2012 | A1 |
20120253343 | McClurken et al. | Oct 2012 | A1 |
20130066310 | Manwaring | Mar 2013 | A1 |
20130158535 | Denis et al. | Jun 2013 | A1 |
20130197502 | Manwaring et al. | Aug 2013 | A1 |
20140188105 | Conley et al. | Jul 2014 | A1 |
20160317209 | Cosmescu | Nov 2016 | A1 |
Number | Date | Country |
---|---|---|
0 544 274 | Nov 1992 | EP |
62204739 | Sep 1987 | JP |
2009504313 | Feb 2009 | JP |
2008295905 | Mar 2015 | JP |
9637156 | Nov 1996 | WO |
9723169 | Jul 1997 | WO |
9838932 | Sep 1998 | WO |
2007037785 | Apr 2007 | WO |
2010141417 | Sep 2010 | WO |
Entry |
---|
Reexam Cert 4794 For 5,697,536, Jun. 10, 2003, Eggers et al. |
International Search Report and Written Opinion dated Nov. 8, 2010 for PCT Appln No. PCT/US2010/048115, filed Sep. 8, 2010, 15 pages. |
Partial Translation of Japanese Patent Laid-Open No. S62-204739. |
International Search Report and Written Opinion, dated Mar. 30, 2017, PCT App. No. PCT/US2016/067101, filed Dec. 16, 2016, 25 pages. |
Number | Date | Country | |
---|---|---|---|
20170172646 A1 | Jun 2017 | US |
Number | Date | Country | |
---|---|---|---|
62269235 | Dec 2015 | US |